Real World Performance of The Afirma Genomic Sequencing Classifier (GSC) - A Meta-analysis.

RW data for the Afirma GSC demonstrates significantly better oSP and oPPV performance compared to the VS, indicating an increased yield of cancers for resected GSC suspicious nodules. The higher BCR likely increases the overall rate of clinical observation in lieu of surgery.